1. Home
  2. MYNZ vs LTRY Comparison

MYNZ vs LTRY Comparison

Compare MYNZ & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • LTRY
  • Stock Information
  • Founded
  • MYNZ 2021
  • LTRY 2015
  • Country
  • MYNZ Germany
  • LTRY United States
  • Employees
  • MYNZ N/A
  • LTRY N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • LTRY Computer Software: Prepackaged Software
  • Sector
  • MYNZ Health Care
  • LTRY Technology
  • Exchange
  • MYNZ Nasdaq
  • LTRY Nasdaq
  • Market Cap
  • MYNZ 9.8M
  • LTRY 8.8M
  • IPO Year
  • MYNZ 2021
  • LTRY N/A
  • Fundamental
  • Price
  • MYNZ $0.36
  • LTRY $1.29
  • Analyst Decision
  • MYNZ Buy
  • LTRY
  • Analyst Count
  • MYNZ 2
  • LTRY 0
  • Target Price
  • MYNZ $3.00
  • LTRY N/A
  • AVG Volume (30 Days)
  • MYNZ 1.4M
  • LTRY 325.1K
  • Earning Date
  • MYNZ 08-13-2024
  • LTRY 08-20-2024
  • Dividend Yield
  • MYNZ N/A
  • LTRY N/A
  • EPS Growth
  • MYNZ N/A
  • LTRY N/A
  • EPS
  • MYNZ N/A
  • LTRY N/A
  • Revenue
  • MYNZ $895,479.00
  • LTRY $6,626,564.00
  • Revenue This Year
  • MYNZ $67.40
  • LTRY N/A
  • Revenue Next Year
  • MYNZ $191.13
  • LTRY N/A
  • P/E Ratio
  • MYNZ N/A
  • LTRY N/A
  • Revenue Growth
  • MYNZ 69.00
  • LTRY 75.84
  • 52 Week Low
  • MYNZ $0.32
  • LTRY $0.82
  • 52 Week High
  • MYNZ $4.71
  • LTRY $13.00
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 39.72
  • LTRY 47.82
  • Support Level
  • MYNZ $0.34
  • LTRY $1.45
  • Resistance Level
  • MYNZ $0.46
  • LTRY $2.20
  • Average True Range (ATR)
  • MYNZ 0.07
  • LTRY 0.33
  • MACD
  • MYNZ 0.00
  • LTRY 0.07
  • Stochastic Oscillator
  • MYNZ 9.09
  • LTRY 33.91

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About LTRY Lottery.com Inc.

Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

Share on Social Networks: